Metraipolis › archive › dc_84d1bb768563
C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease — Europe PMC PMID:41599628
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41599628
- DOI
- 10.3390/ph19010026
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T11:42:58.528Z
- SHA-256 of the archived text
dac7e99ab6f4264f1aae037794176426f436020a296b330a755e9f8e154df622- Stable URL of this page
https://metraipolis.com/documento/dc_84d1bb768563
How to cite
C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease — Europe PMC PMID:41599628 — Europe PMC (en), https://europepmc.org/article/MED/41599628 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84d1bb768563 (Metraipolis archive dc_84d1bb768563, sha256 dac7e99ab6f4264f1aae037794176426f436020a296b330a755e9f8e154df622)
BibTeX
@misc{dc84d1bb768563,
title = {C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease — Europe PMC PMID:41599628},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41599628},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84d1bb768563; sha256 dac7e99ab6f4264f1aae037794176426f436020a296b330a755e9f8e154df622},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599628. Agents can read the archived copy with the MCP tool read_document.